Upload
vuongdat
View
219
Download
0
Embed Size (px)
Citation preview
Directorate of Surveillance and health
GHSA - ACTION PACKAGE PREVENT 4: IMMUNIZATION
INDONESIA
Director of Surveillance and Health Quarantine Ministry of Health - Indonesia
Action Package Commitments
Action Package Leading Countries Contributing Countries
Immunization (Prevent-4)
Italy, Portugal India, Pakistan, Republic of Korea, Saudi Arabia, United Arab Emirates, Yemen
GHSA Goal GHSA Objective GHSA 5-Year Target
Prevent
Avoidable
Epidemics
Reducing the
number and
magnitude of
infectious disease
outbreaks.
A functioning national vaccine delivery
system – with nationwide reach,
effective distributions, access for
marginalized populations,
adequate cold chain, and ongoing
quality control – that is able to respond
to new disease threats.
Indicator P.7.1 Vaccine coverage (measles) as part of National Program
1. Less than 50% 2. 50 – 69% 3. 70 – 89% 4. 90% 5. 95%
Score 4: Demonstrated capacity
Interoperable district- based
immunization information system
Low vaccination rates in small sub
population s and at risk groups
EVM in Indonesia - 2015
P.4.2. National Vaccines Access and Delivery
Indicator
• Adequate funding for procurement of temperature monitoring devices
• Adequate quality cold chain equipment and include in the CCE Inventory
• EVM Self-Assessments implemented in all Provinces and Districts
• On-the-job training in stock management provided
Score 5: Sustainable capacity
26/1,000 LB (DHS 2012)
www.childmortality.org 198 countries
MDG target 2015 23/1,000 LB
55,2% kematian bayidisebabkan oleh diare dan pneumonia
Diare; 31,4
Pnemonia; 23,8
Meningitis/ensefalitis; 9.3
Kelainan saluran pencernaan; 6,4
Kelainan jantung
congenital dan hidrosefalus ; 5,8
Sepsis; 4,1
Tetanus; 2,9
Malnutrisi; 2,3 TB; 1,2
Campak; 1,2
Lain-lain; 11.6 55,2% pneumonia, diarrhoea
12.2% congernital anomalies
9.3% meningo-encephalitis
Infant cause of death (BHR 2007)
2015
34/1000 (DHS th 2007)
61/1000 LB (DHS 1991)
●
41.2%
New Vaccine Priority
Plan 2015 2016 2017 2018 2019
Switching
tOPV to bOPV April
IPV July
MR Phase I Campaign Phase
II dan III
HPV 2 Districts in Yogyakarta
JE
JE Surveillance NRA JE Campaign
8 sentinels High Riks Area
PCV
Pilot project
Central Lombok
Pneumo whole cell Pilot project at 3 provinces
PCV13 Clinical Trial (BF) Pneumoccus whole cell (BF)
Rotavirus
Clinical Trial: Rota Virus 3 (RV3) (BF,
Melbourne Uni, UGM)
Pilot project
Yogyakarta and Klaten
GHSA Roadmap on
Immunization - Indonesia
2015
• Achieving 93% high quality of MCV 1
• Maintaining high OPV to be at least 95%
• Achieving at least 95% coverage of ORI and other VPDs
2016 • Addressing immunization gap for measles through Crash
Program
• IPV introduction into routine immunization
• Maintaining 100% vaccine, cold chain eq. and other logistic
2017 • Conducting antibody survey for polio after IPV
introduction
• MR campaign with 95% target coverage
• At least 80% sufficient cold chain equipment
2018 • Basic health survey for DPT HepB and
Measles coverage
• MR campaign with 95% target coverage
• At least 90% sufficient cold chain equipment
2019
• Introduction MR into NIP
• Providing 100% sufficient cold
chain equipment
9
thank you